Millennium Management
EDIT icon

Millennium Management’s Editas Medicine EDIT Stock Holding History

Millennium Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-30,000
Closed -$1.7M – 6879
2021
Q2 		$1.7M Buy
30,000
+10,000
+50% +$369K ﹤0.01% 4153
2021
Q1 		$840K Buy
+20,000
New +$1.14M ﹤0.01% 4379

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Millennium Management's EDIT Position: Q1 2026 in Review

Millennium Management sold out of Editas Medicine (EDIT) in Q1 2026, closing a stake of 162,330 shares — an estimated $333K sold.

Millennium Management first reported a position in EDIT in Q2 2016 and held it in 35 quarters. The position peaked at $26.2M in Q4 2021. 207 funds tracked by Wall St. Rank hold EDIT as of Q1 2026.

  • Millennium Management reported no remaining Editas Medicine position as of Q1 2026 after selling out during the quarter.
  • Millennium Management sold 162,330 Editas Medicine shares in Q1 2026, an estimated $333K.
  • Millennium Management first reported a position in Editas Medicine in Q2 2016 and held it in 35 quarters.
  • Millennium Management's Editas Medicine position peaked at $26.2M in Q4 2021.
  • 207 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.